Loading patent…
AssigneeCompass Pathfinder Limited
InventorsDerek John Londesbrough, Christopher Brown, Julian Scott Northen, Gillian Moore, David E. Nichols, Hans Åke Eriksson, George Goldsmith, Ekaterina Malievskaia, Manon Cecile Elisabeth Veraart, Lars Christian Wilde
Estimating the term…
The disclosure provides methods for treating a subject in need thereof comprising administering to the subject a therapeutically-effective dose of psilocybin. The methods described herein may be used to treat a variety of diseases, disorders, and conditions. For example, the methods may be used to treat anxiety disorders, eating disorders, and headache disorders.
A method for treating a substance disorder in a subject in need thereof, the method comprising orally administering to the subject a therapeutically effective amount of an oral dosage form comprising:
A method for treating a substance disorder, the method comprising administering a therapeutically effective amount of psilocybin to a subject in need thereof, wherein the psilocybin comprises crystalline psilocybin characterized by X-ray power diffraction (XRPD) peaks at 11.5±0.1, 12.0±0.1, 14.5±0.1, 17.5±0.1 and 19.7±0.1° 2θ, and wherein the psilocybin has a chemical purity of greater than 97% as determined by HPLC analysis.
Dependencies are inferred from the claim text.